Susquehanna Fundamental Investments, LLC Cabaletta Bio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $41,408 - $180,423	-12,324 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $86,268 - $154,050	12,324 New	12,324 $150,000
Q1 2021 May 17, 2021	SELL	$10.39 - $14.53 $124,887 - $174,650	-12,020 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$9.81 - $15.8 $78,126 - $125,831	-7,964 Reduced 39.85%	12,020 $150,000
Q3 2020 Nov 16, 2020	BUY	$9.71 - $14.41 $194,044 - $287,969	19,984 New	19,984 $217,000

147

50M

19.9K

41.5K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $131M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.